Punjab Chemicals & Crop Protection Ltd
NSE: PUNJABCHEM BSE: 506618Agri
Incorporated in 1975, Punjab Chemicals & Crop Protection Ltd is in the business of Performance Chemicals[1]
₹1,002
52W: ₹876 — ₹1666
PE 19.5 · Book ₹361 · +178% vs bookMarket Cap₹1,229 Cr
Stock P/E19.5Price to Earnings
ROCE17.6%Return on Capital
ROE15.2%Return on Equity
Div. Yield0.28%Face Value ₹10
Weaknesses
- −The company has delivered a poor sales growth of 8.68% over past five years.
- −Dividend payout has been low at 7.33% of profits over last 3 years
Shareholding Pattern
Promoters39.24%
FIIs3.01%
DIIs0.62%
Public57.14%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 39.22% | 39.22% | 39.22% | 39.22% | 39.22% | 39.22% | 39.22% | 39.24%▲0.0 |
| FIIs | 3.02% | 2.97%▼0.0 | 2.94%▼0.0 | 3.06%▲0.1 | 2.99%▼0.1 | 3.02%▲0.0 | 3.01%▼0.0 | 3.01% |
| DIIs | 0.42% | 0.39%▼0.0 | 0.5%▲0.1 | 0.55%▲0.1 | 0.55% | 0.56%▲0.0 | 0.56% | 0.62%▲0.1 |
| Public | 57.34% | 57.42%▲0.1 | 57.33%▼0.1 | 57.17%▼0.2 | 57.25%▲0.1 | 57.2%▼0.0 | 57.2% | 57.14%▼0.1 |
Financial Statements
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 213.02 | 196.1 | 241.79 | 241.54 | 213.58 | 201.47 | 318.59 | 253.76 | 245.92 | 207.13 |
| Expenses | 187.77 | 182.28 | 213.99 | 216 | 194.02 | 176.42 | 284.55 | 228.45 | 216.43 | 180.5 |
| Operating Profit | 25.25 | 13.82 | 27.8 | 25.54 | 19.56 | 25.05 | 34.04 | 25.31 | 29.49 | 26.63 |
| OPM % | 11.85% | 7.05% | 11.5% | 10.57% | 9.16% | 12.43% | 10.68% | 9.97% | 11.99% | 12.86% |
| Net Profit | 11.74 | 3.27 | 13.5 | 12.16 | 6.65 | 7.46 | 20.08 | 17.39 | 13.99 | 9.98 |
| EPS ₹ | 9.57 | 2.67 | 11.01 | 9.92 | 5.42 | 6.08 | 16.38 | 14.18 | 11.41 | 8.14 |
AI Insights
Revenue Trend
Mar 2026 revenue at ₹1,025Cr, up 14.1% YoY. OPM at 11%.
Debt Position
Borrowings at ₹154Cr. Debt-to-equity ratio: 0.36x. Healthy balance sheet.
Capex Cycle
CWIP at ₹17Cr (6% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 0.62% (+0.42pp change). FIIs: 3.01% (+0.04pp change). Promoters hold 39.24%.
Margin & Efficiency
ROCE improving from 12% (Mar 2015) to 18% (Mar 2026). Working capital days: 59.
Valuation
PE 19.5x with 17.6% ROCE. Price is 178% above book value of ₹361. Dividend yield: 0.28%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 11 May - Transcript of Earnings Conference Call Q4 & FY26 held on May 5, 2026
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 5 May - Audio recording of Q4 and FY26 earnings call, held May 5, 2026, is now available online.
- Announcement under Regulation 30 (LODR)-Investor Presentation 5 May - Investor Presentation- Financial Overview-Q4 & FY26
- Announcement under Regulation 30 (LODR)-Newspaper Publication 2 May - Newspaper Publication in respect of Audited (Standalone and Consolidated) Financial Results for the quarter and year ended March 31, 2026
- Announcement under Regulation 30 (LODR)-Change in Management 1 May - Board approved FY26 audited results, recommended Rs.3 dividend, and appointed auditors on May 1, 2026.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse